166 related articles for article (PubMed ID: 22315139)
1. Evaluation of oxidative stress markers and vascular risk factors in patients with diabetic peripheral neuropathy.
El Boghdady NA; Badr GA
Cell Biochem Funct; 2012 Jun; 30(4):328-34. PubMed ID: 22315139
[TBL] [Abstract][Full Text] [Related]
2. HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients.
Su JB; Zhao LH; Zhang XL; Cai HL; Huang HY; Xu F; Chen T; Wang XQ
Cardiovasc Diabetol; 2018 Mar; 17(1):47. PubMed ID: 29598819
[TBL] [Abstract][Full Text] [Related]
3. A Retrospective Study on the Time in Range of Blood Glucose and Type 2 Diabetic Peripheral Neuropathy.
Li M; Wu K; Chang J; Jiang WC
Biomed Res Int; 2022; 2022():2743679. PubMed ID: 35937384
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of prevalence and association of peripheral neuropathy in Indian patients with newly diagnosed type 2 diabetes mellitus.
Gill HK; Yadav SB; Ramesh V; Bhatia E
J Postgrad Med; 2014; 60(3):270-5. PubMed ID: 25121366
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and risk factors of diabetic peripheral neuropathy in Type 2 diabetes mellitus patients with overweight/obese in Guangdong province, China.
Li L; Chen J; Wang J; Cai D
Prim Care Diabetes; 2015 Jun; 9(3):191-5. PubMed ID: 25163987
[TBL] [Abstract][Full Text] [Related]
6. Diabetic neuropathy is not associated with homocysteine, folate, vitamin B12 levels, and MTHFR C677T mutation in type 2 diabetic outpatients taking metformin.
Russo GT; Giandalia A; Romeo EL; Scarcella C; Gambadoro N; Zingale R; Forte F; Perdichizzi G; Alibrandi A; Cucinotta D
J Endocrinol Invest; 2016 Mar; 39(3):305-14. PubMed ID: 26233336
[TBL] [Abstract][Full Text] [Related]
7. Glycated albumin indicates peripheral diabetic neuropathy.
Wang N; Guo C; Han P; Li T
Acta Diabetol; 2016 Dec; 53(6):973-979. PubMed ID: 27573202
[TBL] [Abstract][Full Text] [Related]
8. Alterations in circulating angiogenic and anti-angiogenic factors in type 2 diabetic patients with neuropathy.
Motawi TK; Rizk SM; Ibrahim IA; El-Emady YF
Cell Biochem Funct; 2014 Mar; 32(2):155-63. PubMed ID: 23913471
[TBL] [Abstract][Full Text] [Related]
9. Thiols, malonaldehyde and total antioxidant status in the Turkish patients with type 2 diabetes mellitus.
Duman BS; Oztürk M; Yilmazeri S; Hatemi H
Tohoku J Exp Med; 2003 Nov; 201(3):147-55. PubMed ID: 14649736
[TBL] [Abstract][Full Text] [Related]
10. Total vascular risk as a strong correlate of severity of diabetic peripheral neuropathy in Nigerian Africans.
Owolabi MO; Ipadeola A
Ethn Dis; 2012; 22(1):106-12. PubMed ID: 22774318
[TBL] [Abstract][Full Text] [Related]
11. Optimal glycaemic and blood pressure but not lipid targets are related to a lower prevalence of diabetic microvascular complications.
Bashir M; Elhadd T; Dabbous Z; Gul W; Salameh O; Siddiqui M; Al-Muhannadi H; Petropoulos I; Khan A; Ponirakis G; Malik RA
Diabetes Metab Syndr; 2021; 15(5):102241. PubMed ID: 34390975
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with peripheral neuropathy in type 2 diabetes: Subclinical versus confirmed neuropathy.
Unmar Y; Zafar MI; Gao F
J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):337-342. PubMed ID: 28585130
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Peripheral Neuropathy Using Measurement of the Current Perception Threshold with the Neurometer® in patients with type 1 diabetes mellitus.
Lv SL; Fang C; Hu J; Huang Y; Yang B; Zou R; Wang FY; Zhao HQ
Diabetes Res Clin Pract; 2015 Jul; 109(1):130-4. PubMed ID: 25981398
[TBL] [Abstract][Full Text] [Related]
15. The prevalence and associated risk factors of peripheral diabetic neuropathy in Hamedan, Iran.
Kiani J; Moghimbeigi A; Azizkhani H; Kosarifard S
Arch Iran Med; 2013 Jan; 16(1):17-9. PubMed ID: 23273229
[TBL] [Abstract][Full Text] [Related]
16. Determinants of Diabetic Peripheral Neuropathy and Their Clinical Significance: A Retrospective Cohort Study.
Cheng Y; Cao W; Zhang J; Wang J; Liu X; Wu Q; Lin Q
Front Endocrinol (Lausanne); 2022; 13():934020. PubMed ID: 35957831
[TBL] [Abstract][Full Text] [Related]
17. Ambulatory screening of diabetic neuropathy and predictors of its severity in outpatient settings.
Qureshi MS; Iqbal M; Zahoor S; Ali J; Javed MU
J Endocrinol Invest; 2017 Apr; 40(4):425-430. PubMed ID: 27848229
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and Risk Factors for Diabetic Peripheral Neuropathy in Type 2 Diabetic Patients From 14 Countries: Estimates of the INTERPRET-DD Study.
Lu Y; Xing P; Cai X; Luo D; Li R; Lloyd C; Sartorius N; Li M
Front Public Health; 2020; 8():534372. PubMed ID: 33194943
[No Abstract] [Full Text] [Related]
19. The Contemporary Prevalence of Diabetic Neuropathy in Type 1 Diabetes: Findings From the T1D Exchange.
Mizokami-Stout KR; Li Z; Foster NC; Shah V; Aleppo G; McGill JB; Pratley R; Toschi E; Ang L; Pop-Busui R; ;
Diabetes Care; 2020 Apr; 43(4):806-812. PubMed ID: 32029635
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum homocysteine level in the development of diabetic peripheral neuropathy.
Zheng LQ; Zhang HL; Guan ZH; Hu MY; Zhang T; Ge SJ
Genet Mol Res; 2015 Nov; 14(4):15365-75. PubMed ID: 26634502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
